BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

Clinical trial NCT07715136 · RECRUITING

Trial details

NCT number: NCT07715136
Sponsor: iCell Gene Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Myopathy

Start date: 2025-03-20
Primary completion: 2027-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.